Taiwanese regenerative medicine company founded in 2010 with laboratories at the National Biotechnology Research Park in Taipei and in Hsinchu, which develops stem cell therapies. Produces adipose derived mesenchymal stem cell products under good tissue and manufacturing practice for clinical trials in critical limb ischaemia, liver cirrhosis, osteoarthritis and neurological disease, provides cell manufacturing and banking services and works with hospitals in Taiwan and Japan on regenerative medicine programmes.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen